Gadavist 10 mmol/10 ML vial 10ML
Ended Awarded
- Contract number
- SPE2DX25F6QXR
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $6,197
Award facts
- Contract value 100% obligated
- $6,196.98 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp was awarded a delivery order valued at $6,196.98 by the Defense Logistics Agency's Medical Supply Chain on June 27, 2025, for the supply of Gadavist 10 mmol/10 ml vials. This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of June 30, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026.
As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen supplies a broad portfolio of pharmaceutical products and medical commodities to support military and veteran healthcare systems. Gadavist is a contrast agent used in medical imaging procedures, reflecting the company's role in fulfilling specialized pharmaceutical needs across the Defense Health Agency and other federal healthcare entities. The underlying IDC structure allows AmerisourceBergen to efficiently deliver diverse pharmaceutical products to support military healthcare programs globally, with the DLA planning to establish additional Pharmaceutical Prime Vendor Global Program Generation V contracts across multiple regions in the coming years.
Quick answers
Who was awarded contract SPE2DX25F6QXR?
SPE2DX25F6QXR was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on June 27, 2025.
How much is contract SPE2DX25F6QXR worth?
The government has obligated $6,197 on SPE2DX25F6QXR.
Is contract SPE2DX25F6QXR an order under another contract?
Yes. SPE2DX25F6QXR is a delivery order under SPE2DX15D1053, an indefinite delivery contract.
Was contract SPE2DX25F6QXR competed?
The extent of competition for SPE2DX25F6QXR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award